SOUTH SAN FRANCISCO, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, […]
Company focuses efforts and resources on advancing SRF617 and SRF388; Implements strategic restructuringInitial clinical updates for SRF617 and SRF388 expected […]